Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Evaluation of Clinical and Immunological Alterations Associated with ICF Syndrome
Ist Teil von
Journal of clinical immunology, 2024-01, Vol.44 (1), p.26-26, Article 26
Ort / Verlag
New York: Springer US
Erscheinungsjahr
2024
Quelle
SpringerLink
Beschreibungen/Notizen
Purpose
Immunodeficiency with centromeric instability and facial anomalies (ICF) syndrome is a rare autosomal recessive combined immunodeficiency. The detailed immune responses are not explored widely. We investigated known and novel immune alterations in lymphocyte subpopulations and their association with clinical symptoms in a well-defined ICF cohort.
Methods
We recruited the clinical findings from twelve ICF1 and ICF2 patients. We performed detailed immunological evaluation, including lymphocyte subset analyses, upregulation, and proliferation of T cells. We also determined the frequency of circulating T follicular helper (cT
FH
) and regulatory T (Treg) cells and their subtypes by flow cytometry.
Results
There were ten ICF1 and two ICF2 patients. We identified two novel homozygous missense mutations in the
ZBTB24
gene. Respiratory tract infections were the most common recurrent infections among the patients. Gastrointestinal system (GIS) involvements were observed in seven patients. All patients received intravenous immunoglobulin replacement therapy and antibacterial prophylaxis; two died during the follow-up period. Immunologically, CD4
+
T-cell counts, percentages of recent thymic emigrant T cells, and naive CD4
+
T decreased in two, five, and four patients, respectively. Impaired T-cell proliferation and reduced CD25 upregulation were detected in all patients. These changes were more prominent in CD8
+
T cells. GIS involvements negatively correlated with CD3
+
T-, CD3
+
CD4
+
T-, CD16
+
CD56
+
NK-cell counts, and CD4
+
/CD8
+
T-cell ratios. Further, we observed expanded cT
FH
cells and reduced Treg and follicular regulatory T cells with a skewing to a T
H
2-like phenotype in all tested subpopulations.
Conclusion
The ICF syndrome encompasses various manifestations affecting multiple end organs. Perturbed T-cell responses with increased cT
FH
and decreased Treg cells may provide further insight into the immune aberrations observed in ICF syndrome.